Functional Neuroimaging Effects of Cognitive Remediation Training - Full Text View

Functional Neuroimaging Effects of Cognitive Remediation Training

This study has been completed.

Sponsors and Collaborators:	University of Minnesota Minnesota Medical Foundation
Information provided by:	University of Minnesota
ClinicalTrials.gov Identifier:	NCT00481156

Purpose

The purpose of this study is to examine behavioral and functional brain changes occuring as a result of cognitive remediation training in patients with schizophrenia. Extension and specificity of related changes will also be examined.

Condition	Intervention
Schizophrenia	Behavioral: Cognitive Remediation Behavioral: Cognitive Behavioral Social Skills Training

MedlinePlus related topics:

Schizophrenia

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Single Group Assignment

Further study details as provided by University of Minnesota:

Primary Outcome Measures:

Working Memory performance
Brain activation

Estimated Enrollment:	18
Study Start Date:	September 2005

Eligibility

Ages Eligible for Study:	18 Years to 55 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Diagnosis of schizophrenia or schizoaffective disorder
Stable outpatient

Exclusion Criteria:

Current drug abuse or dependence
History of neurological damage, disorder, or disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00481156

Locations


United States, Minnesota
	University of Minnesota
	Minneapolis, Minnesota, United States, 55455

Sponsors and Collaborators

University of Minnesota

Minnesota Medical Foundation

Investigators


Principal Investigator:	Angus W MacDonald, Ph.D.	University of Minnesota

Principal Investigator:	Kelvin O Lim, Ph.D.	University of Minnesota

More Information

Study ID Numbers:	0404M58647, CogRehab
First Received:	May 30, 2007
Last Updated:	May 30, 2007
ClinicalTrials.gov Identifier:	NCT00481156
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Schizophrenia

Mental Disorders

Psychotic Disorders

Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on October 03, 2008